Pneumonia News and Research

Latest Pneumonia News and Research

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Researches have been investigating the possibility of using convalescent plasma to help patients recover from COVID-19.

15 Dec 2021

Colorado hospitals in ‘critical condition’ as state weathers another surge

Harold Burch's home has a spectacular view in Paonia, a rural part of Colorado's Western Slope at the foot of Mount Lamborn. But the landscape has been little consolation to the 60-year-old as he has battled a cascade of health problems during the pandemic.

15 Dec 2021

Frequent cognitive impairments after 4-month follow-up in ICU COVID-19 patients

Results from a recent observational study published in the Journal Of The Neurological Sciences found that after a 4-month follow-up, ICU patients with severe COVID-19 illness were more likely to have mild cognitive impairment with features related to a diffuse encephalopathy than patients with mild infection who do not need a ventilator. Additionally, ICU patients experienced more significant impairment in executive function. All neurological deficits involve the peripheral nervous system.

14 Dec 2021

Severity of SARS-CoV-2 compared to other human coronaviruses in children

Researchers observed that symptom presentation of SARS-CoV-2 infections at the community level was very similar to that of endemic human coronavirus infections.

14 Dec 2021

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Researchers from the Duke Molecular Physiology Institute have been investigating genetic associations with more severe disease and examining the associations that certain genetic features have with other diseases.

13 Dec 2021

Novel breathalyzer relies on viral RNA detection to diagnose SARS-CoV-2

In a new study in The Journal of Molecular Diagnostics, published by Elsevier, investigators report on the design and testing of a breathalyzer, known as the Bubbler, that relies on viral RNA detection to diagnose SARS-CoV-2.

13 Dec 2021

Simple diagnostic model can accurately predict risk for community acquired pneumonia in children

Diagnosis of community acquired pneumonia in children usually involves x-rays, despite recommendations to limit their use by professional societies.

13 Dec 2021

Sarcopenia and COVID-19

The present study attempts to investigate if sarcopenia, which is a condition where there is loss of skeletal muscle mass and function, may result in poor clinical outcomes in COVID-19 patients.

13 Dec 2021

How LA, calling the shots on school vaccine mandates, can lead the way on covid rules

On March 31, 1977, as a measles epidemic swept through Los Angeles, the county health department issued an ultimatum to the parents of the county's 1.6 million schoolchildren: Get your kids vaccinated within a month or keep them home.

13 Dec 2021

Nasal infection drives lethal lung injury due to SARS-CoV-2 in mice

A new study demonstrates lethal infection of the olfactory epithelium in a mouse model that could help understand the mechanisms of COVID-19.

12 Dec 2021

Statistical model builds SARS-CoV-2 interactome with miRNAs, protein-coding genes, and co-infecting microbes

A team of researchers recently developed a statistical modeling method known as multiple-layer crosstalk (MLCrosstalk).

12 Dec 2021

AI-based technology to identify patients at risk of serious illness as a result of blood infections

A new technology developed at Tel Aviv University will make it possible, using artificial intelligence, to identify patients who are at risk of serious illness as a result of blood infections.

8 Dec 2021

Hypercoagulability of the blood responsible for cardiac thrombosis in COVID-19 patients

Researchers examined autopsy tissue samples of hearts from patients who died early in the COVID-19 pandemic.

7 Dec 2021

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Octapharma USA today announced the U.S. Food & Drug Administration has approved cutaquig [Immune globulin, Subcutaneous (Human)-hipp, 16.5% Solution] for the treatment of pediatric patients age 2 and older with primary humoral immunodeficiency (PI). The FDA previously approved cutaquig for adults with PI.

7 Dec 2021

People who exercise regularly have lower risk of developing and dying from pneumonia

People who exercise regularly can reduce their risk of developing and dying from pneumonia, new research has found.

7 Dec 2021

Poolbeg and University College Dublin sign an Option Agreement to license melioidosis vaccine candidate

Poolbeg Pharma, 'Poolbeg' or the 'Company', a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has signed an Option Agreement to licence MelioVac, a vaccine for melioidosis, with University College Dublin and its inventor, Associate Professor Siobhán McClean, through NovaUCD, the university's knowledge transfer office.

7 Dec 2021

Pneumonia News and Research

Latest Pneumonia News and Research

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Colorado hospitals in ‘critical condition’ as state weathers another surge

Frequent cognitive impairments after 4-month follow-up in ICU COVID-19 patients

Severity of SARS-CoV-2 compared to other human coronaviruses in children

Phenome study reveals alternate associations with SARS-CoV-2 risk loci

Novel breathalyzer relies on viral RNA detection to diagnose SARS-CoV-2

Simple diagnostic model can accurately predict risk for community acquired pneumonia in children

Sarcopenia and COVID-19

How LA, calling the shots on school vaccine mandates, can lead the way on covid rules

Nasal infection drives lethal lung injury due to SARS-CoV-2 in mice

Statistical model builds SARS-CoV-2 interactome with miRNAs, protein-coding genes, and co-infecting microbes

AI-based technology to identify patients at risk of serious illness as a result of blood infections

Hypercoagulability of the blood responsible for cardiac thrombosis in COVID-19 patients

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

People who exercise regularly have lower risk of developing and dying from pneumonia

Poolbeg and University College Dublin sign an Option Agreement to license melioidosis vaccine candidate

Exploring SARS-CoV-2 vaccine responsiveness in immunosuppressed patients

An analysis of risk factors and symptom presentation among groups at risk for SARS-CoV-2 infection

Maternal morbidities and outcomes in pregnant women with COVID-19

New approach to COVID-19 immune profiling using blood-based machine learning

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pneumonia News and Research

Latest Pneumonia News and Research

Innovation in neuroscience drug discovery - eBook eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in